Device |
anti-glutamate receptor (type nmda) ifa |
Regulation Description |
Multiple autoantibodies immunological test system. |
Definition |
Intended for the qualitative determination of autoantibodies against glutamate receptor (type NMDA) in human serum. Used as an aid in the diagnosis of anti-glutamate receptor (type NMDA) autoimmune encephalitis in conjunction with other laboratory and clinical findings. |
Physical State |
Solid, liquid |
Technical Method |
Immunofluorescent assay with multiple substrates |
Target Area |
Human serum |
Regulation Medical Specialty |
Immunology |
Review Panel |
Immunology |
Product Code | OSK |
Premarket Review |
Division of Immunology and Hematology Devices
(DIHD)
Division of Immunology and Hematology Devices
(DIHD)
|
Submission Type |
510(k)
|
Regulation Number |
866.5660
|
Device Class |
2
|
Total Product Life Cycle (TPLC) |
TPLC Product Code Report
|
GMP Exempt? |
No
|
Summary Malfunction Reporting |
Eligible |
Implanted Device? |
No
|
Life-Sustain/Support Device? |
No
|
Third Party Review
|
Accredited Persons
|